FSM Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
FSM Wealth Advisors's ABBV Position: Q2 2026 in Review
FSM Wealth Advisors reduced its AbbVie (ABBV) stake by 8.8% in Q2 2026, selling an estimated $94.9K and leaving 4,589 shares worth $1.15M. The position accounts for 0.12% of the portfolio, ranked #99.
FSM Wealth Advisors first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.36M in Q3 2025. 2,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- FSM Wealth Advisors held 4,589 shares of AbbVie worth $1.15M as of Q2 2026.
- FSM Wealth Advisors sold 441 AbbVie shares in Q2 2026, an estimated $94.9K.
- AbbVie made up 0.12% of FSM Wealth Advisors's portfolio in Q2 2026, its #99 holding.
- FSM Wealth Advisors first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
- FSM Wealth Advisors's AbbVie position peaked at $1.36M in Q3 2025.
- 2,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.